Gimsilumab (Anti-CSF2 / GM-CSF)
Gimsilumab (Anti-CSF2 / GM-CSF) (A2853-GRP)
Products
Description
Gimsilumab (Anti-CSF2 / GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the myeloid cell growth factor and inflammatory mediator granulocyte-macrophage colony-stimulating factor (GM-CSF) with potential immunomodulating activity. MW : 145.8 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2853 |
| Target | SARS-CoV |